| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |